Treatment with 100 mg/kg corylin in the AOM/DSS mice led to significantly decreased cancer stem cell and intestinal epithelial cell proliferation, including LGR5, CD44, Ki67, PCNA, BrdU, and Cyclin D1 levels, compared with the AOM/DSS group (Figure 8A). Here, CD44 is linked to cancer.